Meihua International Medical Technologies (MHUA) raised $36 million in its Nasdaq debut this week, the first Chinese firm to list in the US since October 2021. The maker of disposable medical products popped 29% on its first day, before plummeting 30% on day two, finishing Thursday 10% below the offer price.
Chinese firms seeking to list in the US have been sandwiched between newly aggressive regulators in both countries...
To read the rest of the article, sign up for a free trial of IPO Pro.
